Cargando…

Interferon-beta represses cancer stem cell properties in triple-negative breast cancer

Triple-negative breast cancer (TNBC), the deadliest form of this disease, lacks a targeted therapy. TNBC tumors that fail to respond to chemotherapy are characterized by a repressed IFN/signal transducer and activator of transcription (IFN/STAT) gene signature and are often enriched for cancer stem...

Descripción completa

Detalles Bibliográficos
Autores principales:	Doherty, Mary R., Cheon, HyeonJoo, Junk, Damian J., Vinayak, Shaveta, Varadan, Vinay, Telli, Melinda L., Ford, James M., Stark, George R., Jackson, Mark W.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	National Academy of Sciences 2017
Materias:	Biological Sciences
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5748193/ https://www.ncbi.nlm.nih.gov/pubmed/29229854 http://dx.doi.org/10.1073/pnas.1713728114

Ejemplares similares

The opposing effects of interferon-beta and oncostatin-M as regulators of cancer stem cell plasticity in triple-negative breast cancer
por: Doherty, Mary R., et al.
Publicado: (2019)

Using interferon-beta to combat cancer stem cell properties in triple negative breast cancer
por: Doherty, Mary R., et al.
Publicado: (2018)

Response to interferons and antibacterial innate immunity in the absence of tyrosine‐phosphorylated STAT1
por: Majoros, Andrea, et al.
Publicado: (2016)

Qualitative and Quantitative Image-Based Biomarkers of Therapeutic Response in Triple-Negative Breast Cancer
por: Golden, Daniel I., et al.
Publicado: (2018)

IFNβ-dependent increases in STAT1, STAT2, and IRF9 mediate resistance to viruses and DNA damage
por: Cheon, HyeonJoo, et al.
Publicado: (2013)

Cancer Stem Cell Plasticity Drives Therapeutic Resistance
por: Doherty, Mary R., et al.
Publicado: (2016)

Neoadjuvant therapy for early-stage breast cancer: the clinical utility of pertuzumab
por: Gollamudi, Jahnavi, et al.
Publicado: (2016)

Cooperative Transcriptional Activation of Antimicrobial Genes by STAT and NF-κB Pathways by Concerted Recruitment of the Mediator Complex
por: Wienerroither, Sebastian, et al.
Publicado: (2015)

Interferon-beta enhances sensitivity to gemcitabine in pancreatic cancer
por: Blaauboer, Amber, et al.
Publicado: (2020)

The TRRAP transcription cofactor represses interferon-stimulated genes in colorectal cancer cells
por: Detilleux, Dylane, et al.
Publicado: (2022)

Repression of Alzheimer's beta-Secretase
por: Liao, Francesca-Fang, et al.
Publicado: (2013)

Antimicrobial exposure is associated with decreased survival in triple-negative breast cancer
por: Ransohoff, Julia D., et al.
Publicado: (2023)

Induced Pluripotent Stem Cell-Based Cancer Vaccines
por: Ouyang, Xiaoming, et al.
Publicado: (2019)

Shared and Unique Features of Human Interferon-Beta and Interferon-Alpha Subtypes
por: Wittling, Megen C., et al.
Publicado: (2021)

Multi-cancer computational analysis reveals invasion-associated variant of desmoplastic reaction involving INHBA, THBS2 and COL11A1
por: Kim, Hoon, et al.
Publicado: (2010)

PAPAyA: a platform for breast cancer biomarker signature discovery, evaluation and assessment
por: Janevski, Angel, et al.
Publicado: (2009)

Beta-interferons in multiple sclerosis
por: Aggarwal, Sourabh, et al.
Publicado: (2010)

Immunomodulatory activity of interferon-beta
por: Kasper, Lloyd H, et al.
Publicado: (2014)

Interferons Alpha, Beta, and Omega
por: Meager, Anthony
Publicado: (1998)

Oxidized and Aggregated Recombinant Human Interferon Beta is Immunogenic in Human Interferon Beta Transgenic Mice
por: van Beers, Miranda M. C., et al.
Publicado: (2011)

Phase 1b study of berzosertib and cisplatin in patients with advanced triple-negative breast cancer
por: Telli, Melinda L., et al.
Publicado: (2022)

Inference of Disease-Related Molecular Logic from Systems-Based Microarray Analysis
por: Varadan, Vinay, et al.
Publicado: (2006)

Regulation of IMP3 by EGFR Signaling and Repression by ERβ: Implications for Triple Negative Breast Cancer
por: Samanta, Sanjoy, et al.
Publicado: (2012)

Binding blockade between TLN1 and integrin β1 represses triple-negative breast cancer
por: Zhang, Yixiao, et al.
Publicado: (2022)

Multiple human beta interferon genes
Publicado: (1982)

Teach to Beat Cancer: An Integral Component of the Case Comprehensive Cancer Center Youth Enjoy Science Program
por: Junk, Damian J., et al.
Publicado: (2022)

PRC2 activates interferon-stimulated genes indirectly by repressing miRNAs in glioblastoma
por: Shivram, Haridha, et al.
Publicado: (2019)

MYC promotes immune-suppression in triple-negative breast cancer via inhibition of interferon signaling
por: Zimmerli, Dario, et al.
Publicado: (2022)

Identifying homologous recombination deficiency in breast cancer: genomic instability score distributions differ among breast cancer subtypes
por: Lenz, Lauren, et al.
Publicado: (2023)

An anti-cancer surveillance by the interplay between interferon-beta and retinoblastoma protein RB1
por: Qin, Albert
Publicado: (2023)

Lead Aggravates Viral Disease and Represses the Antiviral Activity of Interferon Inducers
por: Gainer, Joseph H.
Publicado: (1974)

High Glucose Represses the Anti-Proliferative and Pro-Apoptotic Effect of Metformin in Triple Negative Breast Cancer Cells
por: Varghese, Sharon, et al.
Publicado: (2019)

GBP5 Repression Suppresses the Metastatic Potential and PD-L1 Expression in Triple-Negative Breast Cancer
por: Cheng, Shun-Wen, et al.
Publicado: (2021)

Pregnancy outcomes in interferon-beta-exposed patients with multiple sclerosis: results from the European Interferon-beta Pregnancy Registry
por: Hellwig, Kerstin, et al.
Publicado: (2020)

Adenovirus protein VII binds the A-box of HMGB1 to repress interferon responses
por: Arnold, Edward A., et al.
Publicado: (2023)

Variable window binding for mutually exclusive alternative splicing
por: Anastassiou, Dimitris, et al.
Publicado: (2006)

Response to Interferon-Beta Treatment in Afro-Caribbeans with Multiple Sclerosis
por: Jeannin, S., et al.
Publicado: (2011)

Identification of Shared Genes and Pathways: A Comparative Study of Multiple Sclerosis Susceptibility, Severity and Response to Interferon Beta Treatment
por: Mahurkar, Sunil, et al.
Publicado: (2013)

Effects of Interferon Beta in COVID-19 adult patients: Systematic Review
por: Sosa, Juan Pablo, et al.
Publicado: (2021)

Synergistic inhibition of human cytomegalovirus replication by interferon-alpha/beta and interferon-gamma
por: Sainz, Bruno, et al.
Publicado: (2005)

Cannot write session to /tmp/vufind_sessions/sess_mchtt630r6v2lshp16lt6f9bvd